Technique Β· Evidence
En bloc explant: where the evidence stands
Established indications, patient preference, technical considerations, and honest evidence assessment.
February 4, 2026 Β· Dr. Ayhan IΕΔ±k Erdal, MD, FACS, FEBOPRAS
En bloc capsulectomy has been one of the most discussed techniques in modern explant surgery. The evidence base helps clarify when it provides clinical benefit and when it represents patient choice without distinct clinical superiority.
The technique
En bloc (French for "as a block") capsulectomy removes the breast implant and surrounding scar tissue capsule together as a single, intact unit β without opening the capsule. The capsule is never breached during the operation. The dissection plane is around the outside of the capsule rather than through or within it.
This contrasts with standard total capsulectomy where the capsule is opened to remove the implant first, then the capsule is removed (in pieces) separately.
Established indications
BIA-ALCL diagnosis or strong suspicion
Strongest clinical evidence. BIA-ALCL cells exist within the capsule fluid (seroma). Standard explant that opens the capsule risks releasing tumor cells into surrounding tissue. En bloc removal contains the entire tumor environment for clean extraction. This is the standard surgical treatment for confirmed BIA-ALCL β curative for early-stage disease in over 95% of cases.
Suspected silicone rupture with extracapsular spread
If silicone gel may have spread beyond the capsule, opening the capsule could disperse silicone further into surrounding tissue. En bloc contains the gel and contaminated capsule for clean removal. Less common indication but established benefit.
BIOCELL macrotextured prophylactic explant (patient preference)
For asymptomatic patients with BIOCELL implants choosing prophylactic explant for BIA-ALCL prevention, en bloc is often preferred. Theoretical benefit: removes any subclinical disease that might be present. Patient psychological benefit: complete capsule removal feels appropriate for prevention-focused decision.
Patient-preference indications
Breast implant illness (BII) explant
Many BII patients specifically request en bloc capsulectomy. Reasoning combines:
- Theoretical containment β if BII is caused by something within the capsule, en bloc removes it completely.
- Symbolic completeness β total removal feels appropriate for patients pursuing explant for symptom resolution.
- Psychological benefit β autonomy and respect for patient decision-making.
Clinical evidence for en bloc benefit specifically for BII (vs total capsulectomy) is limited. Some patient cohorts report better outcomes with en bloc; others show similar outcomes with total capsulectomy. The symptom-resolution rates after explant (50-70% significant improvement) appear similar between approaches in available data.
Modern practice supports patient choice β surgeons accommodate the request because the technique is safe when properly performed and patients report meaningful psychological benefit from complete capsule removal.
Where en bloc is not specifically indicated
- Routine implant exchange of intact non-BIOCELL implants β standard explant equivalent.
- Capsular contracture without rupture β total capsulectomy usually sufficient.
- Aesthetic preference change without BII concerns β standard exchange technique.
- Asymmetry or malposition revision β pocket modification rather than total capsule removal.
For these indications, en bloc adds operative complexity without distinct clinical benefit. Standard explant or total capsulectomy is appropriate.
Technical considerations
| Aspect | Standard total capsulectomy | En bloc capsulectomy |
|---|
| Capsule handling | Capsule opened, implant removed first, capsule removed in pieces | Capsule never opened; capsule + implant removed together |
| Dissection plane | Inside capsule and around capsule | Around outside of capsule only |
| Operative time | 90-120 minutes | 120-180 minutes |
| Posterior dissection difficulty | Standard | Higher β capsule wall must be dissected from chest wall |
| Surgeon experience required | Standard plastic surgery | Specific en bloc training preferred |
| Bleeding risk | Standard | Slightly elevated |
| Recovery | Standard | 1-2 weeks longer typical |
| Cost premium | Standard | β¬1,000-β¬1,500 additional |
The autonomy framing
Modern practice has shifted toward respecting patient choice in explant technique. Patients who choose en bloc:
- For clinical indications (BIA-ALCL, suspected rupture): receive en bloc as standard treatment.
- For BIOCELL prophylaxis: receive en bloc as commonly recommended approach.
- For BII concerns: receive en bloc as honored patient preference.
- For other reasons: discussed with surgeon based on specific clinical context.
The honest framing combines clinical evidence and patient autonomy: en bloc is clinically standard for established indications and reasonable patient preference for others. Surgeons with sufficient en bloc experience can offer the technique safely; patient choice is respected within the framework of safe surgical practice.
Frequently asked questions
Is en bloc capsulectomy actually better than total capsulectomy?
For specific indications β yes, with established evidence. For BIA-ALCL prevention or treatment: en bloc keeps potential tumor cells contained β clear clinical benefit. For ruptured silicone with extracapsular spread: en bloc contains dispersed silicone β clear benefit. For BII without rupture: theoretical advantage but limited definitive evidence vs total capsulectomy. Modern practice supports en bloc for clinical indications and patient preference; clinical advantage specific to BII is plausible but not established.
Why do many BII patients specifically request en bloc?
Three reasons. Symbolic completeness β total removal feels appropriate for patients pursuing implant removal for BII concerns. Theoretical containment β if BII is caused by something within the capsule (not definitively established), en bloc ensures complete capsule removal. Psychological benefit β patient autonomy and respect for their decision-making preferences. Modern practice supports patient request even when clinical advantage isn't definitive β the technique is safe when properly performed.
How is en bloc technically different from total capsulectomy?
Total capsulectomy: capsule opened to remove implant, then capsule removed in pieces. En bloc: capsule never opened β dissection occurs around the outside of capsule, capsule + implant removed together as single intact unit. Technically more challenging β requires careful dissection planes, particularly the posterior plane against chest wall. Operative time 30-60 minutes longer. Surgeon experience matters.
Are there risks specific to en bloc?
Yes β somewhat elevated. The more extensive dissection (around entire capsule outside) creates: increased blood loss, more potential for chest wall injury during posterior dissection, longer recovery, and somewhat higher complication rates than standard total capsulectomy. The risks are manageable with surgeon experience and don't outweigh benefits for indicated cases (BIA-ALCL, ruptured silicone). For elective indications, the risk-benefit is patient-specific.
Do all surgeons do en bloc?
No β surgical experience with en bloc varies. Surgeons who specifically train in BIA-ALCL management or who serve patients with BIOCELL implants typically have substantial en bloc experience. Other surgeons may have limited experience. For patients pursuing en bloc, surgeon experience matters substantially β ask specifically about en bloc case volume and outcomes. Modern plastic surgery training increasingly includes en bloc technique due to its specific indications.
Related references